Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) (ALLEGRO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00509145
Recruitment Status : Completed
First Posted : July 31, 2007
Last Update Posted : February 20, 2012
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceutical Industries